Press Releases

Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day

Quotient Sciences Strengthens Its Top Team with Three New Appointments

NOTTINGHAM, UK; 18 March 2024 – Drug development and manufacturing accelerator Quotient Sciences has announced major changes to its commercial and scientific executive leadership team, strengthening its position as a global leader in the sector.

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

Veramed appoints Karen Curran as Chief Strategy Officer

Specialist Biometrics CRO, Veramed has announced the appointment of Karen Curran as Chief Strategy Officer.

LogiPharma Delivers Diversity, Equity, and Inclusion as a Key Theme for 2024

To mark International Women’s Day, LogiPharma, the largest global event for life sciences supply chain professionals, has reinforced its commitment to diversity, equity, and inclusion (DE&I) as one of the key themes for this year's conference.

Catawba Research Appoints Julie Arnold as New Head of Project Management to Drive Growth and Innovation

Catawba Research today introduced Julie Arnold as its vice president of project management.

Catawba Research Appoints Syed Faridi as New Head of Business Development

Catawba Research welcomes Syed Faridi as its Vice President of Global Business Development.

Empros Pharma edges closer to filling the gap in the market for safe and effective oral weight management treatment

Swedish biopharma company reports positive topline data for phase 2b trial of weight management treatment with responders demonstrating up to 23% in weight loss

Phastar Vice President Prof Jennifer Visser-Rogers Named in Women in Data® Twenty in Data & Technology

Phastar Vice President Prof Jennifer Visser-Rogers Named in Women in Data® Twenty in Data & Technology Prof Visser-Rogers chosen for showcase of inspirational, trailblazing and dedicated women in data and tech.

Amerigo Scientific Releases Cyclic-di-GMP Assay to Simplify Cellular Function Analysis

Hovione partners with Dragonfly Technologies to offer micellar chemistry technology to customers as a sustainable alternative to conventional chemical processes

CD BioSciences Unveiled WMicroTrackers, Powered by Non-invasive Tracking Technology

Cresset Increases Its North America Presence with New Boston Site

Drug discovery specialists Cresset have announced the latest phase of their international expansion with the launch of a new facility in Boston to cement their existing commercial presence in North America

Greenphire Adds Industry Veteran Dan Shannon as New Chief Experience Officer

Dan Shannon joins Greenphire as Chief Experience Officer.

CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award

CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award 2024 Annual Association of Clinical Data Management (ACDM24) recognizes CluePoints’ improved methodology to proactively identify and address data quality.

Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials

Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials

WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges

WCG’s Statistical Consulting Solutions empower biotechnology firms, CROs, pharmaceutical companies, medical device manufacturers, government agencies, and non-profit organizations with comprehensive statistical support across all stages of clinical trial design and regulatory strategy.

Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform

Synexa Life Sciences has announced the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics